Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. Zucca
Ets1 Positively Regulates Faim3 in Activated B Cell-Like (Abc) Diffuse Large B Cell Lymphoma (Dlbcl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Sakk 35/15: A Phase I Trial of Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Eg-011 Is a Novel Small Molecule With in Vitro and in Vivo Anti-Tumor Activity Against Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Copanlisib Synergies With Conventional and Targeted Agents Including Venetoclax in Preclinical Models of B- And T-Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Combinatorial Screening of the Pi3k Inhibitor Copanlisib in T Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Integration Between Metabolic Tumour Volume and Metabolic Heterogeneity Predicts Outcome of DLBCL Lymphoma Patients in the Sakk 38/07 Study Cohort
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Multi-Omics Landscape of Splenic Marginal Zone Lymphoma (Smzl) - Interim Analysis of Ielsg46 Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Mechanisms of Secondary Resistance to Idelalisib in Marginal Zone Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Ets1 Phosphorylation at Thr38 (Pets1) Is Associated With Cell of Origin (Coo), Cell Cycle Activation, and Inferior Outcome in Diffuse Large B Cell Lymphoma (Dlbcl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Simultaneous Bet/Crebbp/Ep300 Targeting Approach Compared to Single Bet or Crebbp/Ep300 Inhibition in Diffuse Large B-Cell Lymphoma (Dlbcl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
‹
1
2
3
›
